The Association of Vitamin D Deficiency and Incident Frailty in Older Women: The Role of Cardiometabolic Diseases

ObjectivesEvidence suggests vitamin D deficiency is associated with developing frailty. However, cardiometabolic factors are related to both conditions and may confound and/or mediate the vitamin D-frailty association. We aimed to determine the association of vitamin D concentration with incidence of frailty, and the role of cardiometabolic diseases (cardiovascular disease, diabetes, hyperlipidemia, hypertension) in this relationship. DesignProspective longitudinal cohort study (7 visits from 1994-2008). SettingBaltimore, Maryland. ParticipantsThree hundred sixty-nine women from the Women's Health and Aging Study II aged 70-79years, free of frailty at baseline. MeasurementsSerum circulating 25-hydroxyvitamin D (25[OH]D) concentration was assessed at baseline and categorized as: <10; 10-19.9; 20-29.9; and 30ng/mL. Frailty incidence was determined based on presence of three or more criteria: weight loss, low physical activity, exhaustion, weakness, and slowness. Cardiometabolic diseases were ascertained at baseline. Analyses included Cox regression models adjusted for key covariates. ResultsIncidence rate of frailty was 32.2 per 1,000 person-years in participants with 25(OH)D<10ng/mL, compared to 12.9 per 1,000 person-years in those with 25(OH)D30ng/mL (mean follow-up=8.53.7years). In cumulative incidence analyses, those with lower 25(OH)D exhibited higher frailty incidence, though differences were non-significant (P=.057). In regression models adjusted for demographics, smoking, and season, 25(OH)D<10ng/mL (vs 30ng/mL) was associated with nearly three-times greater frailty incidence (hazard ratio (HR)=2.77, 95% CI=1.14, 6.71, P=.02). After adjusting for BMI, the relationship of 25(OH)D<10ng/mL (vs 30ng/mL)with incident frailty persisted, but was attenuated after further accounting for cardiometabolic diseases (HR=2.29, 95% CI=0.92, 5.69, P=.07). ConclusionLow serum vitamin D concentration is associated with incident frailty in older women; interestingly, the relationship is no longer significant after accounting for the presence of cardiometabolic diseases. Future studies should explore mechanisms to explain this relationship.